JP2021530482A5 - - Google Patents

Info

Publication number
JP2021530482A5
JP2021530482A5 JP2021500520A JP2021500520A JP2021530482A5 JP 2021530482 A5 JP2021530482 A5 JP 2021530482A5 JP 2021500520 A JP2021500520 A JP 2021500520A JP 2021500520 A JP2021500520 A JP 2021500520A JP 2021530482 A5 JP2021530482 A5 JP 2021530482A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
acid
tumor
alcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2021500520A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021530482A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/040264 external-priority patent/WO2020023191A1/en
Publication of JP2021530482A publication Critical patent/JP2021530482A/ja
Publication of JP2021530482A5 publication Critical patent/JP2021530482A5/ja
Withdrawn legal-status Critical Current

Links

JP2021500520A 2018-07-09 2019-07-02 腫瘍を減少させる製剤およびその使用方法 Withdrawn JP2021530482A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862695613P 2018-07-09 2018-07-09
US62/695,613 2018-07-09
PCT/US2019/040264 WO2020023191A1 (en) 2018-07-09 2019-07-02 Tumor reduction formulations and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2021530482A JP2021530482A (ja) 2021-11-11
JP2021530482A5 true JP2021530482A5 (cg-RX-API-DMAC7.html) 2022-07-07

Family

ID=75267393

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021500520A Withdrawn JP2021530482A (ja) 2018-07-09 2019-07-02 腫瘍を減少させる製剤およびその使用方法

Country Status (11)

Country Link
EP (1) EP3820482A4 (cg-RX-API-DMAC7.html)
JP (1) JP2021530482A (cg-RX-API-DMAC7.html)
KR (1) KR20220098082A (cg-RX-API-DMAC7.html)
CN (1) CN112584841A (cg-RX-API-DMAC7.html)
AU (1) AU2019309757A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021000279A8 (cg-RX-API-DMAC7.html)
CA (1) CA3105717A1 (cg-RX-API-DMAC7.html)
EA (1) EA202190201A1 (cg-RX-API-DMAC7.html)
IL (1) IL280000A (cg-RX-API-DMAC7.html)
PH (1) PH12021550033A1 (cg-RX-API-DMAC7.html)
WO (1) WO2020023191A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020186392A1 (zh) * 2019-03-15 2020-09-24 大连大学 甘氨胆酸在制备抗肿瘤药物中的应用
EP3968785A4 (en) 2019-05-14 2023-01-11 Tyme, Inc. COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER
IL293706A (en) * 2019-12-09 2022-08-01 Tyme Inc Pharmaceutical compositions and methods
US10905698B1 (en) 2020-05-14 2021-02-02 Tyme, Inc. Methods of treating SARS-COV-2 infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060135729A (ko) * 2004-01-29 2006-12-29 백스터 인터내셔널 인코포레이티드 중추신경계 전달 증가를 위한 항레트로바이러스제의나노현탁액
WO2006099685A1 (en) * 2005-03-24 2006-09-28 Medical Therapies Limited Method for the prophylaxis or treatment of carcinomas
CN101023940A (zh) * 2006-02-20 2007-08-29 郝守祝 一种紫杉烷类化合物的药用组合物、制备方法及用途
AU2015287749B2 (en) * 2014-07-11 2021-03-11 The Regents Of The University Of California Tumor selective macropinocytosis-dependent rapidly internalizing antibodies
US9687528B2 (en) * 2014-12-23 2017-06-27 Steven Hoffman Transdermal formulations
EA201892051A1 (ru) * 2016-03-15 2019-02-28 Тайм, Инк. Фармацевтические композиции для лечения злокачественного новообразования

Similar Documents

Publication Publication Date Title
Sakaguchi et al. Polyglycolic acid sheets with fibrin glue can prevent esophageal stricture after endoscopic submucosal dissection
EA201790124A1 (ru) Соли берберина, соли урсодезоксихолевой кислоты и их комбинации, способы получения и применения
JP2011511076A5 (cg-RX-API-DMAC7.html)
HRP20210200T1 (hr) Kombinirana antitumorska imunoterapija
Eskiizmir et al. Nanomaterials: promising structures for the management of oral cancer
CN105102002A (zh) 用于在消化道中保护伤口、提供止血或预防粘连的药物组合物
Kim et al. Radiofrequency ablation of parathyroid adenoma in primary hyperparathyroidism
WO2013133873A3 (en) Pharmaceutical compositions of sodium ion and calcium ion and methods for treating cancer, tumor and non-malignancy
BR112022012499A2 (pt) Peptídeo, composição, métodos para tratar um paciente e para tratar uma doença, e, uso de um peptídeo
Ishizuka et al. Experimental evaluation of photocrosslinkable chitosan hydrogel as injection solution for endoscopic resection
Eberspacher et al. Transperineal excision of malignant peripheral nerve sheath tumors of the ischiorectal fossa: Case report of a rare tumor in a frequently forgotten anatomical region
JP2014517038A5 (cg-RX-API-DMAC7.html)
JOP20210118A1 (ar) علاج موضعي للإسهال أو التهاب القولون أو التهاب الأمعاء والقولون الناجم عن مثبط نقطة مراقبة مناعية باستخدام أجسام مضادة وشظايا منها
EA201990883A1 (ru) Соли берберина, соли урсодезоксихолевой кислоты и их комбинации, способы получения и применения
Kawamura et al. Microwave ablation for the control of bleeding from disintegrated mammary tumours in two dogs
JP2017533928A5 (cg-RX-API-DMAC7.html)
Wei et al. High-intensity focused ultrasound leads to histopathologic changes of the inferior turbinate mucosa with allergic inflammation
CN102631645B (zh) 一种治疗乳腺增生、卵巢囊肿的药物
CN206214466U (zh) 一种胃部创面修复装置
RU2847886C1 (ru) Способ мини-инвазивного лечения нейроэндокринных опухолей поджелудочной железы
Mateshuk-Vatseba e-mail: lvatseba@ gmail. com
Dupré et al. High Intensity Focused Ultrasound (HIFU) in Digestive Diseases: An Overview of Clinical Applications for Liver and Pancreatic Tumors
Manta et al. A multimodal, one-session endoscopic approach for management of patients with advanced pancreatic cancer
Fluehler et al. Photodynamic therapy for nonmelanoma skin cancer of the genital area: our experience.
Алексеев et al. Discussion on problems of prostate cancer treatment and the role of cabazitaxel in treatment of patients with metastatic castration-resistant prostate cancer: Decision of the Expert Board